REG - Societe Generale SA Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical CO LTD
RNS Number : 7634ISociete Generale SA28 November 2018FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser:
Société Générale S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Use a separate form for each offeror/offeree
Takeda Pharmaceutical CO LTD
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:
For an opening position disclosure, state the latest practicable date prior to the disclosure
27/11/2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
YES: Shire PLC
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security:
Ordinary
Interests
Short positions
Number
%
Number
%
(1) Relevant securities owned and/or controlled:
1,954,664
0.25
7,780,331
0.99
(2) Cash-settled derivatives:
6,898,733
0.88
0
0.00
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
121,500
0.02
256,000
0.03
TOTAL:
8,974,897
1.14
8,036,331
1.02
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security
Purchase/sale
Number of securities
Price per unit
JPY
Ordinary
Purchase
13,700
4206.1854
Ordinary
Purchase
20,000
4225
Ordinary
Purchase
11,300
4180
Ordinary
Purchase
100
4180
Ordinary
Purchase
300
4180
Ordinary
Purchase
200
4186
Ordinary
Purchase
100
4254.5
Ordinary
Purchase
200
4257
Ordinary
Purchase
300
4257
Ordinary
Purchase
700
4252
Ordinary
Purchase
200
4256
Ordinary
Purchase
200
4212
Ordinary
Purchase
100
4188
Ordinary
Purchase
500
4211
Ordinary
Purchase
1,100
4256
Ordinary
Purchase
300
4211
Ordinary
Purchase
1,100
4254
Ordinary
Purchase
1,100
4211
Ordinary
Purchase
300
4254
Ordinary
Purchase
2,200
4245
Ordinary
Purchase
2,200
4202
Ordinary
Purchase
200
4187
Ordinary
Purchase
500
4206
Ordinary
Purchase
2,200
4204
Ordinary
Purchase
1,100
4227
Ordinary
Purchase
1,100
4193
Ordinary
Purchase
1,100
4229
Ordinary
Purchase
100
4187
Ordinary
Purchase
1,100
4210
Ordinary
Purchase
300
4223
Ordinary
Purchase
2,200
4224
Ordinary
Purchase
1,100
4211
Ordinary
Purchase
600
4189
Ordinary
Purchase
700
4187
Ordinary
Purchase
300
4211
Ordinary
Purchase
200
4192
Ordinary
Purchase
1,100
4197
Ordinary
Purchase
1,100
4195
Ordinary
Purchase
2,200
4218
Ordinary
Purchase
1,100
4218
Ordinary
Purchase
1,100
4213
Ordinary
Purchase
300
4195
Ordinary
Purchase
2,200
4226
Ordinary
Purchase
100
4229
Ordinary
Purchase
900
4187
Ordinary
Purchase
1,100
4229
Ordinary
Purchase
1,000
4232
Ordinary
Purchase
200
4226
Ordinary
Purchase
700
4227
Ordinary
Purchase
1,100
4199
Ordinary
Purchase
1,100
4227
Ordinary
Purchase
1,100
4189
Ordinary
Purchase
1,100
4221
Ordinary
Purchase
2,000
4224
Ordinary
Purchase
100
4187
Ordinary
Purchase
1,100
4195
Ordinary
Purchase
1,100
4200
Ordinary
Purchase
1,100
4196
Ordinary
Purchase
1,100
4191
Ordinary
Purchase
900
4223
Ordinary
Purchase
1,100
4226
Ordinary
Purchase
1,500
4211
Ordinary
Purchase
200
4223
Ordinary
Purchase
500
4224
Ordinary
Purchase
1,100
4201
Ordinary
Purchase
1,100
4193
Ordinary
Purchase
1,100
4199
Ordinary
Purchase
500
4211
Ordinary
Purchase
400
4199
Ordinary
Purchase
1,100
4193
Ordinary
Purchase
1,100
4199
Ordinary
Purchase
1,100
4198
Ordinary
Purchase
200
4197
Ordinary
Purchase
1,100
4211
Ordinary
Purchase
1,100
4200
Ordinary
Purchase
1,100
4213
Ordinary
Purchase
1,100
4197
Ordinary
Purchase
1,000
4212
Ordinary
Purchase
800
4201
Ordinary
Purchase
400
4235
Ordinary
Purchase
400
4237
Ordinary
Purchase
700
4241
Ordinary
Purchase
400
4242
Ordinary
Purchase
600
4246
Ordinary
Purchase
100
4249
Ordinary
Purchase
1,100
4207
Ordinary
Purchase
100
4206
Ordinary
Purchase
600
4193
Ordinary
Purchase
800
4199
Ordinary
Purchase
1,100
4209
Ordinary
Purchase
1,100
4203
Ordinary
Purchase
300
4206
Ordinary
Purchase
300
4206
Ordinary
Purchase
600
4200
Ordinary
Purchase
100
4206
Ordinary
Purchase
400
4205
Ordinary
Purchase
1,100
4212
Ordinary
Purchase
200
4219
Ordinary
Purchase
100
4222
Ordinary
Purchase
1,100
4203
Ordinary
Purchase
600
4211
Ordinary
Purchase
900
4212
Ordinary
Purchase
1,100
4219
Ordinary
Purchase
700
4218
Ordinary
Purchase
300
4198
Ordinary
Purchase
1,100
4218
Ordinary
Purchase
300
4246
Ordinary
Purchase
400
4247
Ordinary
Purchase
200
4247
Ordinary
Purchase
800
4205
Ordinary
Purchase
1,100
4220
Ordinary
Purchase
100
4258
Ordinary
Purchase
800
4205
Ordinary
Purchase
100
4189
Ordinary
Purchase
900
4253
Ordinary
Purchase
1,400
4255
Ordinary
Purchase
100
4255
Ordinary
Purchase
500
4253
Ordinary
Purchase
400
4255
Ordinary
Purchase
100
4245
Ordinary
Purchase
100
4237
Ordinary
Purchase
100
4238
Ordinary
Purchase
600
4204
Ordinary
Purchase
1,200
4231
Ordinary
Purchase
1,600
4229
Ordinary
Purchase
200
4223
Ordinary
Purchase
100
4226
Ordinary
Purchase
1,400
4226
Ordinary
Purchase
2,600
4186
Ordinary
Purchase
1,400
4229
Ordinary
Purchase
1,200
4228
Ordinary
Purchase
800
4216
Ordinary
Purchase
800
4196
Ordinary
Purchase
300
4184
Ordinary
Purchase
1,500
4211
Ordinary
Purchase
400
4231
Ordinary
Purchase
400
4239
Ordinary
Purchase
600
4244
Ordinary
Purchase
1,900
4187
Ordinary
Purchase
1,500
4207
Ordinary
Purchase
100
4218.5
Ordinary
Purchase
100
4197.5
Ordinary
Purchase
600
4200
Ordinary
Purchase
100
4194
Ordinary
Sale
41,800
4180
Ordinary
Sale
700
4186
Ordinary
Sale
1,100
4255
Ordinary
Sale
500
4254
Ordinary
Sale
1,100
4190
Ordinary
Sale
800
4229
Ordinary
Sale
600
4185
Ordinary
Sale
900
4224
Ordinary
Sale
1,100
4225
Ordinary
Sale
100
4187
Ordinary
Sale
200
4229
Ordinary
Sale
1,000
4229
Ordinary
Sale
1,100
4228
Ordinary
Sale
1,100
4190
Ordinary
Sale
500
4257
Ordinary
Sale
600
4253
Ordinary
Sale
800
4257
Ordinary
Sale
900
4236
Ordinary
Sale
700
4233
Ordinary
Sale
1,100
4189
Ordinary
Sale
100
4186
Ordinary
Sale
300
4212
Ordinary
Sale
300
4211
Ordinary
Sale
300
4191
Ordinary
Sale
900
4211
Ordinary
Sale
800
4190
Ordinary
Sale
1,100
4247
Ordinary
Sale
600
4221
Ordinary
Sale
10,000
4180
Ordinary
Sale
10,000
4180
Ordinary
Sale
1,400
4259
Ordinary
Sale
1,100
4199
Ordinary
Sale
1,800
4210
Ordinary
Sale
1,200
4233
Ordinary
Sale
2,300
4200
Ordinary
Sale
900
4196
Ordinary
Sale
1,000
4223
Ordinary
Sale
1,100
4228
Ordinary
Sale
300
4218
Ordinary
Sale
1,400
4227
Ordinary
Sale
1,400
4228
Ordinary
Sale
1,800
4210
Ordinary
Sale
4,000
4198
Ordinary
Sale
1,400
4228
Ordinary
Sale
1,600
4232
Ordinary
Sale
200
4231
Ordinary
Sale
300
4213
Ordinary
Sale
500
4214
Ordinary
Sale
1,100
4232
Ordinary
Sale
1,600
4231
Ordinary
Sale
200
4229
Ordinary
Sale
700
4229
Ordinary
Sale
300
4228
Ordinary
Sale
1,900
4212
Ordinary
Sale
600
4217
Ordinary
Sale
300
4217
Ordinary
Sale
300
4223
Ordinary
Sale
100
4223
Ordinary
Sale
500
4221
Ordinary
Sale
100
4217
Ordinary
Sale
1,800
4213
Ordinary
Sale
1,500
4224
Ordinary
Sale
1,700
4217
Ordinary
Sale
2,000
4209
Ordinary
Sale
1,300
4225
Ordinary
Sale
100
4224
Ordinary
Sale
900
4219
Ordinary
Sale
100
4218
Ordinary
Sale
100
4217
Ordinary
Sale
900
4218
Ordinary
Sale
2,600
4196
Ordinary
Sale
100
4221
Ordinary
Sale
1,600
4192
Ordinary
Sale
100
4216
Ordinary
Sale
200
4216
Ordinary
Sale
700
4180
Ordinary
Sale
1,900
4256
Ordinary
Sale
1,600
4194
Ordinary
Sale
500
4211
Ordinary
Sale
1,500
4211
Ordinary
Sale
1,500
4211
Ordinary
Sale
2,700
4210
Ordinary
Sale
500
4240
Ordinary
Sale
1,000
4197
Ordinary
Sale
1,400
4201
Ordinary
Sale
1,400
4255
Ordinary
Sale
2,500
4212
Ordinary
Sale
1,500
4211
Ordinary
Sale
100
4210
Ordinary
Sale
2,600
4212
Ordinary
Sale
400
4212
Ordinary
Sale
600
4211
Ordinary
Sale
3,400
4212
Ordinary
Sale
2,300
4201
Ordinary
Sale
1,600
4220
Ordinary
Sale
1,600
4217
Ordinary
Sale
1,200
4218
Ordinary
Sale
500
4243
Ordinary
Sale
2,400
4192
Ordinary
Sale
900
4180
Total Purchases
154,200
Total Sales
163,800
(b) Cash-settled derivative transactions
Class of relevant security
Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities
Price per unit JPY
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security
Product description e.g. call option
Writing, purchasing, selling, varying etc.
Number of securities to which option relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Option money paid/ received per unit JPY
Ordinary
OTC call- option
Selling
131,000
4,600
European
13/12/2018
42.25
(ii) Exercise
Class of relevant security
Product description
e.g. call option
Exercising/ exercised against
Number of securities
Exercise price per unit JPY
(d) Other dealings (including subscribing for new securities)
Class of relevant security
Nature of dealing
e.g. subscription, conversion
Details
Price per unit (if applicable) JPY
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached?
YES
Date of disclosure:
28/11/2018
Contact name:
Olivier Vero
Telephone number:
+44 20 7676 6969
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION
Full name of person making disclosure:
SOCIETE GENERALE SA
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:
Takeda Pharmaceutical CO LTD
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class of relevant security
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
Type
Expiry date
JPY
e.g. American, European etc.
Ordinary
OTC put-option
Sale
15,700
4707
European options
14/12/2018
Ordinary
OTC put-option
Sale
30,000
5075.10
European options
14/12/2018
Ordinary
OTC put-option
Sale
29,600
5073.65
European options
14/12/2018
Ordinary
OTC put-option
Sale
15,500
4491.40
European options
14/12/2018
Ordinary
OTC put-option
Sale
30,700
4533.90
European options
14/12/2018
Ordinary
Listed call-option
Sale
125,000
5500
European options
13/06/2019
Ordinary
OTC call-option
Sale
131,000
4,600
European options
13/12/2018
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the interest or position can be fully understood:
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDRETPGGBCGUPRUBR
Recent news on Takeda Pharmaceutical Co
See all newsREG - Malin Corp PLC - Malin Announces 2021 Full Year Results
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Confirmation of post-offer intention statements
AnnouncementREG - Morgan Stanley&CoLLC Takeda Pharma.Co.Ltd - Form 8.5 (EPT/RI) - Replacement of Takeda
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Statement re Applicable Exchange Rate
AnnouncementREG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - Replacement of Takeda
Announcement